EndoPredict® Predicts the Chemotherapy Benefit in Women with Early ER-positive, HER2-negative Breast Cancer

NEXT STORY
Viral Vector and Plasmid DNA Manufacturing Market is anticipated to surpass US$ 2 Billion by 2027- TMR
PREV STORY
Axiom Real-Time Metrics Exhibiting at Clinical Operations in Oncology Trials West Coast 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

RedHill Biopharma to Present at the BIO Investor Forum 2016

TEL-AVIV, Israel, Oct. 13, 2016 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” ...

author_avatar
NASDAQ Market News

Client Outlook’s eUnity™ Selected as the Enterprise Image Viewing Platform for Tampa General Hospital

WATERLOO, Ontario, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Client Outlook, a leading provider of FDA ...

author_avatar
NASDAQ Market News

Akcea Therapeutics to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate ...

author_avatar
NASDAQ Market News